Article
CpG island methylator phenotype classification improves risk assessment in pediatric T-cell acute lymphoblastic leukemia
22 Jan 2025
Abstract excerpt
ABSTRACT: Current intensive treatment of pediatric T-cell acute lymphoblastic leukemia (T-ALL) has substantial side effects, highlighting a need for novel biomarkers to improve risk stratification. Canonical biomarkers, such as genetics and immunophenotype, are largely not used in pediatric T-ALL stratification. This study aimed to validate the prognostic relevance of DNA methylation CpG island methylator...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
